Annual Immunogenicity & Bioassay Summit

The Annual Immunogenicity & Bioassay Summit is the premier event in the U.S. dedicated to the fields of immunogenicity and bioassays. This 18th installment promises to be a pivotal gathering, bringing together leading experts from various sectors including industry, academia, and regulatory authorities. Attendees will have the opportunity to engage with top-tier professionals and regulatory leaders, sharing insights and exploring the latest advancements in these critical areas of study. The summit is designed for high-value networking and interactive discussions, ensuring that participants can move their programs forward with the knowledge and connections gained.The event features strong representation from the FDA and includes a vibrant exhibit and poster hall that showcases a variety of innovations and research findings. Key exhibitors and speakers include industry giants such as Regeneron, AstraZeneca, Eli Lilly, Merck, Johnson and Johnson, Bristol Myers Squibb, Genentech, Moderna, Novo Nordisk, Bayer, and more. By becoming a sponsor or exhibitor, participants can connect with a focused audience comprising life sciences, pharmaceutical, clinical, healthcare, and IT professionals. This summit offers diverse methods for engaging with esteemed delegates, making it an essential event for anyone looking to influence the future of immunogenicity and bioassay research.